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Background: While Switzerland invests a lot of money in its healthcare system, little is known about the quality of
care delivered. The objective of this study was to assess the quality of care provided to patients with diabetes in
the Canton of Vaud, Switzerland.
Methods: Cross-sectional study of 406 non-institutionalized adults with type 1 or 2 diabetes. Patients’
characteristics, diabetes and process of care indicators were collected using a self-administered questionnaire.
Process indicators (past 12 months) included HbA1C check among HbA1C-aware patients, eye assessment by
ophtalmologist, microalbuminuria check, feet examination, lipid test, blood pressure and weight measurement,
influenza immunization, physical activity recommendations, and dietary recommendations. Item-by-item (each
process of care indicator: percentage of patients having received it), composite (mean percentage of recommended
care: sum of received processes of care / sum of possible recommended care), and all-or-none (percentage of
patients receiving all specified recommended care) measures were computed.
Results: Mean age was 64.4 years; 59% were men. Type 1 and type 2 diabetes were reported by 18.2% and 68.5%
of patients, respectively, but diabetes type remained undetermined for almost 20% of patients. Patients were
treated with oral anti-diabetic drugs (50%), insulin (23%) or both (27%). Of 219 HbA1C-aware patients, 98% reported
≥ one HbA1C check during the last year. Also, ≥94% reported ≥ one blood pressure measurement, ≥ one weight
measurement or lipid test, and 68%, 64% and 56% had feet examination, microalbuminuria check and eye
assessment, respectively. Influenza immunization was reported by 62% of the patients.
The percentage of patients receiving all processes of care ranged between 14.2%-16.9%, and 46.6%-50.7%, when
considering ten and four indicators, respectively. Ambulatory care utilization showed little use of multidisciplinary
care, and low levels of participation in diabetes-education classes.
Conclusions: While routine processes-of-care were performed annually in most patients, diabetes-specific risk
screenings, influenza immunization, physical activity and dietary recommendations were less often reported; this
was also the case for multidisciplinary care and participation in education classes. There is room for diabetes care
improvement in Switzerland. These results should help define priorities and further develop country-specific chronic
disease management initiatives for diabetes.
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Managing chronic diseases, which account for a large
mortality, morbidity and disability burden within com-
munities, requires better integration and coordination of
care. Targeting this goal, the Chronic Care Model pro-
motes teamwork, self-management education for pa-
tients, evidence-based care, and organization of patients’
and professionals’ exchange and transmission of infor-
mation as several important components [1,2]. The
transfer and implementation of evidence-based know-
ledge in practice is nevertheless challenging, and the
quality of care for chronic diseases remains sub-optimal
[3-6]. Diabetes care is not an exception. Indeed, several
population- [7-12] and physician practice-based studies
[13-15] from North American and European countries
have shown that there is much room for improvement
in both processes and outcomes of diabetes care. Some
countries have nevertheless already noticed quality of
care improvements [16-18].
Switzerland is a federal and democratic state compris-
ing of 26 cantons, with about 8 millions residents. The
1996 Law on Health Insurance stipulated that all Swiss
residents must purchase basic health insurance, which
covers a comprehensive basket of goods and services.
Ambulatory care is provided by primary care physicians
and specialists working mostly independently in solo
and small group private practices. Except for insurees
opting for a health insurance plan limiting access to
specialists (gate-keeping principle), in return of lower
premiums, Swiss residents have unlimited access to am-
bulatory care. Hospitals, which provide inpatient care,
can also provide general and specialist ambulatory care.
Switzerland spends around 11% of its GDP on health
[19]. The returns on this investment are an average life-
expectancy above European average, low mortality rates,
and residents’ overall satisfaction with the Swiss health
care system [20,21]. However, data collection, particu-
larly in the ambulatory care sector, remains insufficient
to address whether “Switzerland receives value for money
for its major financial investment in healthcare” [21].
Data on the quality of diabetes care is scarce in Switzerland.
In 1995, a survey showed that several diabetes-specific
checks were self-reported by only a small fraction of pa-
tients with diabetes (microalbuminuria check, glycemic
self-controls, HbA1C, feet examination, respectively 13%,
39%, 53% and 54%) [22]. In 2004, improvements were
shown among patients from a convenience sample of pri-
mary care physicians [23], and the first population-based
measure of prevalence of diabetes was found to be around
7% [24]. However, quality of care data are still infrequently
and unsystematically collected. In addition, when they are
available, they focus on intermediate outcomes, as well as
clinical and biological cardiovascular risk factors [25-27].
Within the development of a regional diabetes program(“Programme cantonal Diabète”) [28], we conducted a
survey to assess the characteristics of patients with dia-
betes as well as the quality of the care they receive. Unlike
previous studies on the quality of care in Switzerland, this
study was population-based, considered a larger number
of indicators and combined both patients’ and physicians’
reported data. The aim of the current paper is to present
results of process of care indicators, as reported by pa-
tients, individually and in combination.
Methods
Study design
This cross-sectional study, conducted in the fall of 2011,
used self-administered paper questionnaires for data
collection.
Setting, participants and recruitment
Patients with diabetes were recruited by community-
based pharmacies registered in the canton of Vaud,
Switzerland, a large French-speaking canton with over
720’000 inhabitants. Sample size calculations were
performed to estimate the number of patients with dia-
betes we would need to recruit to obtain good precision
(i.e. confidence interval width) of process of care indica-
tors (% of patients with specific annual checks); to be
conservative, sample size was calculated around a 50%
point estimate. Taking into account the clustering of
data by pharmacies (40 pharmacies, each recruiting 15
patients, intra-class correlation 0.05, alpha 0.05, beta
0.2), 600 diabetic patients were considered sufficient.
Therefore, we decided to contact 140 pharmacies to get
a minimum of 40 willing to participate. They were ran-
domly selected from a total of 241 pharmacies registered
in the canton in April 2011; 56 finally agreed to partici-
pate (participation rate of 40%) [29]. Patients were eli-
gible if they came to the pharmacy with a prescription
for oral anti-diabetic medications (OAD), insulin, gly-
cemic strips or glucose meter, were aged ≥18 years and
non-institutionalized, and known to have a diagnosis of
diabetes for at least 12 months. Patients not residing in
the canton of Vaud, not speaking or understanding
French well enough, or those presenting with an obvious
cognitive impairment were excluded, as well as women
with gestational diabetes. Out of 1013 eligible patients,
809 accepted to receive the questionnaire and 408 filled
it out and returned it; two patients were excluded be-
cause their treating physicians reported a major cogni-
tive impairment. The final analytical sample therefore
consisted of 406 patients, corresponding to a participa-
tion rate of 50.2% (406/809). Since we collected both pa-
tients’ and physicians’ reported data, treating physicians
(n = 186) were also contacted, with patients’ consent;
almost two-thirds (60%) of them agreed to fill in a brief
questionnaire. Agreement between patients’ and physicians’
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form kappa, was shown to be good for routine process of
care (measurement of blood pressure, HbA1c, weight, and
lipid profile), and less satisfactory for microalbuminuria
check, foot examination and eye assessment (personal
communication, TH Collet).Measure
Data of interest for the current study included self-
reported data targeting patients’ characteristics and health
status (age, gender, socio-economic and insurance status,
place of residence, smoking status, alcohol consumption
using the AUDIT-C questionnaire [30], physical activity
levels using questions from the Swiss Health Survey [31],
weight and height, self-rated health and comorbidities),
and the description of their diabetes (type of diabetes, dis-
ease duration, treatment, diabetes-related complications).
The following ten primary process of care indicators were
also collected (with reference to the past 12 months):
HbA1C check among those who reported knowing what
HbA1C was (yes,1×/year; yes,>1×/year; no; unknown), eye
assessment by ophthalmologist (yes,<1 year ago; yes,
1-2 years ago; yes, >2 years ago; never; unknown), annual
microalbuminuria check (yes; no; unknown), annual feet
examination by physician (yes; no; unknown), annual lipid
test (yes; no; unknown), blood pressure measure (yes,1×/year;
yes, 2-3×/year; yes, ≥4×/year; no; unknown), annual
weight measure (yes; no; unknown), annual influenza
immunization (yes; no; unknown), physical activity recom-
mendations (yes; no; unknown), written or verbal diet rec-
ommendations (yes; no; unknown). Finally, we asked
about secondary process of care measures: i) ambulatory
care visits in the prior 12 months (yes,1×; yes,2-3×; yes,≥ 4×;
no) with the following providers, primary care physicians
(general internal medicine, family medicine or general prac-
tice), diabetologists, nurse specialists, dieticians and podia-
trists, and ii) participation in self-management education
classes (yes, <1 year ago; yes,1-2 years ago; yes, >2 years
ago; never; unknown).
We used three approaches to assess process of care
performance [32]:
 item-by-item: for each single process of care
indicator, percentage of patients having received it
 composite: mean percentage of recommended care
as the sum of received process of care divided by the
sum of possible recommended care
 all-or-none: percentage of patients receiving all
specified recommended care
Combined measures of indicators have been reco-
mmended when item-by-item results are already good
[32]. In this paper, we will refer to the latter two(composite and all-or-none) as combined measures of re-
ceipt of services during the past 12 months.
The combined measures of process of care indicators
were the following: all ten indicators, six “diabetes-
specific” indicators (HbA1C check, eye assessment by
ophtalmologist, micro-albuminuria test, feet examin-
ation, lipid test, influenza immunization, excluding mea-
sures that are normally proposed to any patient such as
blood pressure and weight measurement, physical activ-
ity and diet recommendations), and the four indicators
considered in the 2008 International Commonwealth
Fund Survey (HbA1C check, eye assessment, feet exam-
ination, lipid test) [4]. Because of a skip question survey
method, which limited answers about receipt of HbA1C
tests to those reporting knowing what HbA1C was
(HbA1C-aware patients), we restricted the analysis of
combined measures of receipt of services (that included
HbA1C checks) to this HbA1C-aware sub-group. In
order not to exclude HbA1C unaware patients from all
analysis, we also constructed two combined measures
not considering HbA1C check: all processes of care ex-
cept HbA1C check (n = 9), and five “diabetes-specific”
indicators (all six “diabetes-specific” indicators men-
tioned above, except HbA1C check).
Statistical analysis
Descriptive analyses of primary process of care indica-
tors with confidence intervals around point estimates
(item-by-item measurement) were conducted, taking
into account the hierarchical structure of the data (clus-
ters of pharmacies). Percentages of receipt of processes
of care were based on those who answered the particular
question and not on the total number of participants
(complete case analysis). The exact number of patients
considered in the analysis is specified in all tables.
For sensitivity testing, item-by-item analyses were then
performed assuming worst case and best case scenarios.
In worst case scenarios, we considered patients having
not responded to the question (missing data) or having
chosen “don’t know”, as patients not having received the
process of care during the past 12 months. In best case
scenarios, we considered these same patients as having
received the process of care during the past 12 months.
Analyses of combined measures were both performed
for complete cases and to take into account cases with
missing and “don’t know” data. Including missing and
“don’t know” answers allowed us to consider all patients,
and thus to estimate the lowest (minimal) percentage of
patients who would have received at least a specified
number of processes of care. The highest (maximal) per-
centage of possible patients receiving the specified num-
ber of processes of care was calculated with “don’t
know” answers and missing data counted as receipt of
care. These lowest (minimal) and highest (maximal)
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within which the percentage of patients having received
these processes would lie when considering all targeted
patients. STATA 11.0 was used for all analyses.
Ethical approval was received from the Cantonal Ethics
Committee of Research on Human Beings of the Canton
of Vaud (“Commission cantonale (VD) d’éthique de la
recherche sur l’être humain”, Protocol N° 151/11). Written
informed consent was obtained from all participants, and
data were kept anonymous and confidential.
Results
Descriptive information about the study population is
shown in Table 1. Briefly, mean age was 64.4 years and
the majority of participants (59%) were men. While 16%
were current smokers, 82% were either overweight or
obese, half were considered to engage in at-risk drinkingTable 1 Characteristics of participants (n = 406 diabetic
patients)
Age (n = 406), mean (SD) 64.4 (11.4)
Women (n = 406) 40.6%
Civil status (n = 403)
Single 8.7%
Married/partnership 62.5%
Divorced/separated/widowed 28.8%
Education (n = 392)
Primary 19.1%
Secondary 55.6%
Tertiary 25.3%
Employment status (n = 394)
Full-time 25.1%
Part-time 9.1%
Retired 55.6%
Unemployment/handicapped/student 5.8%
Stay-at-home 4.3%
Place of residence (n = 399)
Urban 38.9%
Semi-urban 27.1%
Rural 34.1%
Current smoking (n = 398) 16.3%
BMI (n = 378)
Overweight 35.7%
Obese 46.3%
Physically inactive (n = 385) 28.6%
Self-reported health (n = 398)
Excellent/very good 15.9%
Good 64.3%
Medium/poor 19.9%behaviour (AUDIT-C scores ≥ 3 for women and ≥ 4 for
men), and almost one-third reported being physically in-
active. Type 1 and type 2 diabetes were reported by
18.2% and 68.5% of patients, respectively. Description of
diabetes type remained undetermined for almost 20% of
patients. The vast majority of patients reported being
treated with anti-diabetic drugs and/or insulin, and at
least one complication of diabetes was reported by
nearly half of all patients. Glucose self-monitoring was
performed by 82% of the patients, and 54% of participants
indicated knowing what HbA1C was. Table 2 displays fur-
ther detailed information on diabetes characteristics.
In item-by-item analysis for receiving at least one spe-
cific process of care during the past 12 months, HbA1C
check was above 90% among those who reported know-
ing what HbA1C was. Similar high percentages were
found for routine clinical tests like blood pressure and
weight measurements, as well as lipid tests. Item-by-
item results remained high for HbA1C check and blood
pressure measurement even when raising the bar to two
or more screens in the past year. Under these parame-
ters, HbA1C and blood pressure checks were reported
by 83.4% (95% CI 77%-88.3%) and 86.5% (83.1%-89.4%)
of the patients, respectively. Physical activity recommen-
dation, feet examination, microalbuminuria test andTable 2 Diabetes characteristics
Type of diabetes (n = 406)
Type 1 12.8%
Type 2 68.5%
Undetermined 18.7%
Duration of the disease (n = 399)
1-5 years 28.3%
6-10 years 23.1%
11-15 years 17.3%
≥16 years 31.3%
Type of treatment (n = 405)
Oral antidiabetic drugs (OAD) 49.6%
Insulin 22.7%
Oral antidiabetic dugs and insulin 26.9%
None/unknown 0.8%
Glucose self-monitoring (n = 398) 82%
Diabetes complications (n = 396)†
At least one 46.7%
Macrovascular complications* 34.9%
Microvascular** 24%
†: Myocardial infarction/angina, stroke, retinopathy (excluding cataract and
glaucoma problems), nephropathy (including dialysis or renal transplantation),
neuropathy (lower limb pain or sensibility problems/ulcer/amputation), severe
hypo or hyperglycemia.
* Myocardial infarction/angina, stroke, neuropathy (lower limb pain or
sensibility problems/ulcer/amputation).
** Retinopathy, nephropathy (including dialysis or renal transplantation).
Peytremann-Bridevaux et al. BMC Health Services Research 2013, 13:232 Page 5 of 10
http://www.biomedcentral.com/1472-6963/13/232influenza vaccination (in descending order of frequency)
were performed less often. While 64% of patients
reported having a microalbuminuria test carried out, it is
worth noting that 14.3% of the patients answered “don’t
know” to that specific question. Eye assessment by an
ophthalmologist and dietary recommendations were the
process of care indicators that ranked the lowest, with
only 56% and 49% of the patients reporting them, re-
spectively (Table 3). However, report of eye assessment
by an ophthalmologist increased to 73.5% (69.4%-77.3%)
when considering a two-year timeframe. Except forTable 3 Primary process of care indicators (item-by-item): rec
order of receipt %
N for each response
modality
R
≥ one HbA1C check (n = 218)* Yes: 214
No: 2
DK: 2
≥ one blood pressure measurement
(n = 399)
Yes: 388
No: 8
DK: 3
≥ one weight measurement (n = 396) Yes: 374
No: 21
DK: 1
≥ one lipid test (n = 401) Yes: 378
No: 13
DK: 10
Physical activity recommendations,
written or verbal (n = 398)
Yes: 277
No: 120
DK: 1
Diabetic foot examination by a physician
(n = 397)
Yes: 265
No: 129
DK: 3
≥ one urine test (for micro-albuminuria)
(n = 399)
Yes: 252
No: 90
DK: 57
Influenza immunization (n = 402) Yes: 250
No: 151
DK: 1
Eye assesment by ophthalmologist
(n = 399)
Yes: 225
No: 166
DK: 8
Diet recommendations, written or verbal
(n = 399)
Yes: 194
No: 203
DK: 2
DK don’t know.
* Among HbA1C aware patients (skip question).
** Don’t know answers and missing data assumed as “no receipt” of process of care
† Don’t know answers and missing data assumed as “receipt” of process of care.those processes of care with high numbers of “don’t
know” answers, worst and best case scenarios results
remained within the 95% confidence interval of point
estimates.
All combined results (composite and all-or-none) are
shown in Table 4. Overall, while patients with diabetes
received 80% of processes of care (i.e. 8 out of 10, or 5
out of 6, or 3 out of 4 processes of care), all processes of
care were received by only less than 20% of patients. In
addition, the mean percentage of care received varied
between 72% and 85%, depending on whether HbA1Ceipt of service during past 12 months, by decreasing
eceipt of
service
(95% CI) Worst case
scenario**
Best case
scenario†
98.1% (95.3%-98.9%) 97.7% 99.1%
96.4% (95.7%-97.0%) 95.6% 98.0%
94.4% (91.4%-96.6%) 92.1% 94.8%
94.2% (91.6%-96.1%) 93.1% 96.8%
69.6% (65.2-71.1%) 68.2% 70.4%
66.8% (61.5%-72.9%) 65.3% 68.2%
63.2% (57.6%-70%) 62.1% 77.8%
62.2% (58.6%-65.5%) 61.6% 62.8%
56.4% (51.4%-61%) 55.4% 59.1%
48.6% (43.2%-54.2%) 47.8% 50.0%
.
Table 4 Primary process of care indicators: combined measures of receipt of service during past 12 months, % (n)
Combined measures among patients who reported knowing what HbA1C is (i.e. among HbA1C-aware patients, n=219)
1) All 10 processes of care §
Complete cases* Composite: mean % of recommended care (SD) 82% (13.5)
(n=175) All-or-none: receipt of10/10 care processes, % (n) 17.7% (31)
All patients (n=219) Lowest ** % (n) – Highest*** % (n) of patients receiving 10/10 care processes 14.2% (31) - 16.9% (37)
Lowest ** % (n) – Highest*** % (n) of patients receiving at least 8/10 care processes 65.3% (143) - 74.4% (163)
2) Six “Diabetes-specific” processes of care †
Complete cases * Composite: mean % of recommended care (SD) 82.4% (15.5)
(n=182) All-or-none: receipt of 6/6 care processes, % (n) 30.2% (55)
All patients (n=219) Lowest ** % (n) – Highest*** % (n) of patients receiving 6/6 care processes 25.1% (55) - 28.8% (63)
Lowest ** % (n) – Highest*** % (n) of patients receiving at least 5/6 care processes 64.4% (141) - 71.2% (156)
3) Restricted list of four processes of care ‡
Complete cases* Composite: mean % of recommended care (SD) 85.3% (16.2)
(n=204) All-or-none: receipt of 4/4 care processes, % (n) 50% (102)
All patients (n=219) Lowest ** % (n) – Highest*** % (n) of patients receiving 4/4 care processes 46.6% (102) - 50.7% (111)
Lowest ** % (n) – Highest*** % (n) of patients receiving at least 3/4 care processes 88.6% (194) - 90.9% (199)
Combined measures without consideration of HbA1C check (i.e. among all patients, irrespective of their HbA1C knowledge status, n=406)
1) Nine processes of care (all 10 except HbA1C) §§
Complete cases* Composite: mean % of recommended care (SD) 75.3% (18)
(n=304) All-or-none: receipt of 9/9 care processes, % (n) 12.5% (38)
All patients (n=406) Lowest ** % (n) – Highest*** % (n) of patients receiving 9/9 care processes 9.4% (38) - 12.3% (50)
Lowest ** % (n) – Highest*** % (n) of patients receiving at least 7/9 care processes 53% (215) - 65.8% (267)
2) Five “Diabetes-specific” process of care (all six “Diabetes-specific” except HbA1C) ††
Complete cases* Composite: mean % of recommended care (SD) 72.6% (22.7)
(n=319) All-or-none: receipt of 5/5 care processes, % (n) 24.1% (77)
All patients (n=406) Lowest ** % (n) – Highest*** % (n) of patients receiving 5/5 care processes 19% (77) - 23.4% (95)
Lowest ** % (n) – Highest*** % (n) receiving at least 4/5 care processes 49.5% (201) - 59.9% (243)
§ HbA1C check (among HbA1C-aware patients who answered the HbA1C process of care question), eye assessment, microalbuminuria check, feet examination, lipid test, blood pressure and weight measurement,
influenza immunization, physical activity and diet recommendations.
* Only results for cases that are “complete”: cases with “don’t know” answers and cases with missing data are dropped from analysis.
** Lowest (minimal) percentage of patients having received at least a certain number of processes of care where “don’t know” and missing data are assumed as “not having received the process of care”.
***Highest (maximal) percentage of patients having received at least a certain number of processes of care where “don’t know” and missing data are assumed as “having received the process of care”.
† HbA1C check (among HbA1C-aware patients who answered the HbA1C process of care question), eye assessment, microalbuminuria check, feet examination, lipid test, influenza immunization.
‡ HbA1C check (among the HbA1C-aware and thus answered the HbA1C process of care question), eye assessment, feet examination, lipid test (diabetes indicator used in the 2008 Commonwealth Fund survey).
§§ Eye assessment, micro-albuminuria test, feet examination, lipid test, blood pressure measure, weight measure, influenza immunization, physical activity recommendations, diet recommendations.
†† Eye assessment, microalbuminuria check, feet examination, lipid test, influenza immunization.
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dicators. Upon looking at combined measures which in-
corporated HbA1C checks (i.e. among HbA1C-aware
patients), the percentage of patients receiving all pro-
cesses of care ranged from 14.2% to 16.9% when all 10
processes of care were targeted, and 46.6% to 50.7%
when the list was restricted to four indicators. Complete
case analyses of all-or-none indicators showed similar
results.
Combined measures excluding HbA1C checks showed
higher percentages of patients receiving all services
when the number of services considered was lowered
(9.4% to12.3% of patients received nine out of nine ser-
vices while 19% to 23.4% of patients received five out of
five services). Higher percentages of receipt of services
were also found when conducting complete case analysis
of all-or-none measures. Finally, restricting analyses to
HbA1C-aware patients yielded slightly better results
(14.2%-16.9% and 25.6%-29.2%, respectively, for nine out
of nine and five out of five services, for example).
Ambulatory care utilization data showed that, while al-
most all patients reported visiting a primary care physician
in the previous 12 months (93.4%), one-third of them did
not see a specialist (diabetologist-endocrinologist), and be-
tween 2/3 and 3/4 of respondents did not consult with
other diabetes-related healthcare professionals (diabetic
nurse specialists, dieticians, or podiatrists) during the past
year (Figure 1). Lastly, attendance at self-management
education classes (group or individual sessions) was low;
only one third reported having ever participated in this
type of class.
Discussion
While routine clinical and laboratory tests (blood pres-
sure and weight measurements, lipid tests) were
performed annually in most patients with diabetes, risk
screenings such as feet examination, microalbuminuria
check and eye assessment, as well as physical activity0
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Figure 1 Percentage of ambulatory care visits (number of
times/year) to various healthcare professionals.and dietary recommendations, and influenza immu-
nization, were less often reported. Also only a minority
of patients reported having received all processes of care.
In addition, a substantial number of patients did not
know the meaning of HbA1c and quite a few did not
specify the type of diabetes they live with. There was also
little evidence for multidisciplinary care, low referrals to
non-physician diabetes healthcare professionals, and low
reporting of patient participation in diabetes education
sessions.
The results of our study are similar to past findings.
However, differences in healthcare organization struc-
ture and variations in measurement of process of care
indicators limit the scope of such comparisons. Most
published results have included self-reported data which
point to better item-by-item outcomes for blood pres-
sure, lipid and HbA1C controls than for annual eye as-
sessment, microalbuminuria check, feet examination,
and influenza vaccination [8,10,12,16,33-35]. Similar in-
dices were found by the European Core Indicators in
Diabetes (EUCID) project, which gathered representative
regional or national quality of care data over 19 coun-
tries [5]. These differences could be explained by the fact
that it is easier to obtain better results for processes of
care that are recommended to be performed more than
once a year (blood pressure controls, HbA1C and lipids
checks) than for those recommended once a year or less
(microalbuminuria, check and feet examination, for
example).
The 2008 Commonwealth Fund population-based sur-
vey collected data on care experiences of sick patients
residing in eight high income countries (Australia,
Canada, France, Germany, Netherlands, New-Zealand,
United Kingdom, United States) [4]. While only
targeting a restricted set of diabetes process of care indi-
cators (HbA1C check, lipid test, eye assessment and feet
examination), the care of Dutch and British patients
consistently ranked among the best, even when consid-
ering item-by-item and all-or-none measures. While
31% and 36% of French and Australian patients reported
all four processes of care, up to 59% and 67% of Dutch
and British patients received all four, respectively. Re-
sults from a similarly constructed indicator among our
HbA1C-aware patients (Table 4) demonstrated that
Swiss performance would probably end up in the middle,
very close to German and US results.
Combined measures of indicators (such as all-or-none)
are recommended when item-by-item results are already
good, because they help identify areas of improvement,
particularly when processes of care are considered [32].
However, a multitude of combinations can be used po-
tentially. Also, good all-or-none results are much harder
to achieve compared to results that measure outcomes
using partial completion of indicators. Examples from
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respondents with diabetes from the 1994 Behavioral Risk
Factor Surveillance System (BRFSS) met all five stan-
dards of care [12], approximately one out of four similar
patients received adequate care as measured by the re-
ceipt of nine out of eleven diabetes care processes in
2009 [8]. There was a greater variation reported in the
national audit of diabetes care in England with 10% of
patients reporting three out of four processes of care
(smoking cessation recommendations, HbA1C, blood
pressure and lipid checks), 70% of the patients signaling
receipt of the following three services (blood pressure,
lipid and HbA1C controls) and 50% of patients reporting
nine out of nine processes of care [33]. Comparisons of
study results are difficult to interpret however, as combi-
nations and measurements of indicators varied between
studies. In fact, less cross-country variations were shown
in the 2008 Commonwealth Fund comparison [4], which
used the same methodology in all countries. Such varia-
tions of results could also be explained by the fact that a
careful selection of indicators is needed when conside-
ring all-or-none measures. Indeed, Nolan et al. re-
commended that the number of indicators remains
small (four to eight), and that they are considered as im-
portant measures and be consensually accepted as the
basis of good care for a given condition. Also, all-or-
none measures magnify measurement errors since “one
unreliable component measure will contaminate the
whole score” [32].
The main strengths of this study are that we used a
population-based sample of patients with diabetes, and
targeted a range of recommended diabetes process of
care indicators. Of course, the first limitation to our re-
sults is the use of self-reported data. Indeed, the accur-
acy of self-report depends on the type of data collected,
and patients with diabetes may over- or underestimate
elements of the care process [36,37]. However, com-
plementary analyses of our data suggested acceptable
agreement between patients’ reported process of care
measures and primary care physicians’ report. Indeed,
while agreement, as measured by uniform kappa, was
good for past 12 months routine process of care such as
measurement of blood pressure, HbA1c, weight, and
lipid profile, it was less satisfactory for procedures such
as microalbuminuria check, foot examination and eye
assessment [TH Collet, personal communication]. The
second limitation is the use of “one check in the past
12 months” time frame for some process of care indica-
tors, which can be questioned. However, expert groups
currently accept this time frame for population-based
quality assessment purposes, which facilitates population-
level comparisons [5,38]. The third limitation is the some-
what smaller than expected sample size. Because we had
more clusters (pharmacies) than we expected, and becauseof our conservative sample size calculations, the precision
around point estimates was nevertheless acceptable [29].
The fourth limitation relates to the representativeness of
our sample of patients with diabetes, which may be
questioned since it was not drawn from a population’s
register. We are nevertheless confident that, in the Swiss
healthcare context, this recruitment method allowed for
representative sampling. Indeed, few comparable charac-
teristics of our patients with diabetes were close to those
of a population-based cohort study conducted in the same
area [[24]; P Marques-Vidal, personal communication].
Another limitation relating to the representativeness of
the sample could be the moderate participation rate of pa-
tients (50%). This participation rate is however acceptable
given that no reminders were sent. It was not feasible to
ask pharmacies to collect additional information such as
contact details of all eligible and possibly participating pa-
tients. Finally, analyses restricted to HbA1C-aware pa-
tients may have biased estimates of combined measures
towards slightly better results (Table 4), without affecting
item-by-item percentages. Indeed, HbA1C-aware patients
were more likely than HbA1C unaware patients to report
type 1 diabetes, present with a longer disease duration
and insulin use, and were more likely to be younger,
more educated and report higher income. However,
HbA1C-aware and unaware patients with diabetes were
not different in terms of gender, civil status, profession,
insurance coverage, smoking, physical activity and self-
reported health.Conclusions
In a wealthy country known for having good overall
health indicators and long life expectancy, the results of
this study showed that even if, on the whole, quality of
diabetes care as measured by specific processes of care
was acceptable, there remained room for further im-
provements. Indeed, special attention should be paid to
diabetes specific risk screens, such as microalbuminuria
check and eye assessment by ophtalmologist, participa-
tion in diabetes (self-management) education classes,
dietary and physical activity recommendations, as well
as multidisciplinary care, since they were all underused.
These unmet targets should help set priorities for the
further development and comprehensive monitoring of
chronic disease management initiatives, such as those
being implemented in several European and North
American countries, as well as in Switzerland.
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